Adrian Kilcoyne - Oct 3, 2022 Form 4 Insider Report for Celularity Inc (CELU)

Role
Executive Vice President, Chief Medical Officer
Signature
/s/ Keary Dunn, Attorney-in-Fact
Stock symbol
CELU
Transactions as of
Oct 3, 2022
Transactions value $
$0
Form type
4
Date filed
10/4/2022, 04:10 PM
Previous filing
Oct 4, 2022
Next filing
Feb 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Stock Option (Right to Buy) Award $0 +66.2K $0.00 66.2K Oct 3, 2022 Class A Common Stock 66.2K $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Issuer's 2021 Equity Incentive Plan. The shares underlying such option vest and become exercisable as follows: 25% on the one-year anniversary of the grant date, with the remainder vesting monthly thereafter so that it will be vested in full on the four-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.

Remarks:

Executive Vice President, Chief Medical Officer